Advertisement

Muscarinic receptor subtypes involved in urothelium-derived relaxatory effects in the inflamed rat urinary bladder

      Abstract

      Functional studies have shown altered cholinergic mechanisms in the inflamed bladder, which partly depend on muscarinic receptor-induced release of nitric oxide (NO). The current study aimed to characterize which muscarinic receptor subtypes that are involved in the regulation of the nitrergic effects in the bladder cholinergic response during cystitis. For this purpose, in vitro examinations of carbachol-evoked contractions of inflamed and normal bladder preparations were performed. The effects of antagonists with different selectivity for the receptor subtypes were assessed on intact and urothelium-denuded bladder preparations. In preparations from cyclophosphamide (CYP; in order to induce cystitis) pre-treated rats, the response to carbachol was about 75% of that of normal preparations. Removal of the urothelium or administration of a nitric oxide synthase inhibitor re-established the responses in the inflamed preparations. Administration of 4-diphenylacetoxy-N-methylpiperidine (4-DAMP) inhibited the carbachol-induced contractile responses of preparations from CYP pre-treated rats less potently than controls. Pirenzepine and p-fluoro-hexahydro-sila-diphenidol (pFHHSiD) affected the carbachol-induced contractile responses to similar extents in preparations of CYP pre-treated and control rats. However, the Schild slopes for the three antagonists were all significantly different from unity in the preparations from CYP pre-treated rats. Again, l-NNA or removal of the urothelium eliminated any difference compared to normal preparations.
      This study confirms that muscarinic receptor stimulation in the inflamed rat urinary bladder induces urothelial release of NO, which counteracts detrusor contraction.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Autonomic Neuroscience: Basic and Clinical
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Andersson K.E.
        • Arner A.
        Urinary bladder contraction and relaxation: physiology and pathophysiology.
        Physiol. Rev. 2004; 84: 935-986
        • Andersson K.E.
        • Persson K.
        Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.
        Scand. J. Urol. Nephrol. Suppl. 1995; 175: 43-53
        • Andersson M.C.
        • Tobin G.
        • Giglio D.
        Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat.
        Br. J. Pharmacol. 2008; 153: 1438-1444
        • Apodaca G.
        The uroepithelium: not just a passive barrier.
        Traffic. 2004; 5: 117-128
        • Aronsson P.
        • Andersson M.
        • Ericsson T.
        • Giglio D.
        Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder.
        Basic Clin. Pharmacol. Toxicol. 2010; 107: 603-613
        • Arunlakshana O.
        • Schild H.O.
        Some quantitative uses of drug antagonists.
        Br. J. Pharmacol. Chemother. 1959; 14: 48-58
        • Birder L.A.
        • De Groat W.C.
        Mechanisms of disease: involvement of the urothelium in bladder dysfunction.
        Nat. Clin. Pract. Urol. 2007; 4: 46-54
        • Chancellor M.B.
        • Yoshimura N.
        Treatment of interstitial cystitis.
        Urology. 2004; 63: 85-92
        • Chess-Williams R.
        • Chapple C.R.
        • Yamanishi T.
        • Yasuda K.
        • Sellers D.J.
        The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro.
        J. Auton. Pharmacol. 2001; 21: 243-248
        • Coleman R.A.
        • Eglen R.M.
        • Jones R.L.
        • Narumiya S.
        • Shimizu T.
        • Smith W.L.
        • Dahlen S.E.
        • Drazen J.M.
        • Gardiner P.J.
        • Jackson W.T.
        • et al.
        Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.
        Adv. Prostaglandin Thromboxane Leukot. Res. 1995; 23: 283-285
        • Cox P.J.
        Cyclophosphamide cystitis—identification of acrolein as the causative agent.
        Biochem. Pharmacol. 1979; 28: 2045-2049
        • De Groat W.C.
        The urothelium in overactive bladder: passive bystander or active participant?.
        Urology. 2004; 64: 7-11
        • Dubbin P.N.
        • Zambetis M.
        • Dusting G.J.
        Inhibition of endothelial nitric oxide biosynthesis by N-nitro-l-arginine.
        Clin. Exp. Pharmacol. Physiol. 1990; 17: 281-286
        • Eglen R.M.
        • Choppin A.
        • Watson N.
        Therapeutic opportunities from muscarinic receptor research.
        Trends Pharmacol. Sci. 2001; 22: 409-414
        • Eglen R.M.
        • Nahorski S.R.
        The muscarinic M(5) receptor: a silent or emerging subtype?.
        Br. J. Pharmacol. 2000; 130: 13-21
        • Finney S.M.
        • Andersson K.E.
        • Gillespie J.I.
        • Stewart L.H.
        Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?.
        BJU Int. 2006; 98: 503-507
        • Giglio D.
        • Ryberg A.T.
        • To K.
        • Delbro D.S.
        • Tobin G.
        Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats.
        Auton. Neurosci. 2005; 122: 9-20
        • Giglio D.
        • Tobin G.
        Muscarinic receptor subtypes in the lower urinary tract.
        Pharmacology. 2009; 83: 259-269
        • Hammer R.
        • Berrie C.P.
        • Birdsall N.J.M.
        • Burgen A.S.V.
        • Hulme E.C.
        Pirenzepine distinguishes between different subclasses of muscarinic receptors.
        Nature. 1980; 283: 90-92
        • Hegde S.S.
        • Choppin A.
        • Bonhaus D.
        • Briaud S.
        • Loeb M.
        • Moy T.M.
        • Loury D.
        • Eglen R.M.
        Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
        Br. J. Pharmacol. 1997; 120: 1409-1418
        • Kanai A.
        • Andersson K.E.
        Bladder afferent signaling: recent findings.
        J. Urol. 2010; 183: 1288-1295
        • Logadottir Y.R.
        • Ehren I.
        • Fall M.
        • Wiklund N.P.
        • Peeker R.
        • Hanno P.M.
        Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis.
        J. Urol. 2004; 171 (discussion 50–1): 1148-1150
        • Longhurst P.A.
        • Leggett R.E.
        • Briscoe J.A.
        Characterization of the functional muscarinic receptors in the rat urinary bladder.
        Br. J. Pharmacol. 1995; 116: 2279-2285
        • Mok M.H.
        • Knight G.E.
        • Andrews P.L.
        • Hoyle C.H.
        • Burnstock G.
        The effects of cyclophosphamide on neurotransmission in the urinary bladder of Suncus murinus, the house musk shrew.
        J. Auton. Nerv. Syst. 2000; 80: 130-136
        • Rahnama'i M.S.
        • Van Koeveringe G.A.
        • Essers P.B.
        • De Wachter S.G.
        • De Vente J.
        • Van Kerrebroeck P.E.
        • Gillespie J.I.
        Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria.
        J. Urol. 2010; 183: 1241-1247
        • Selo-Ojeme D.O.
        • Onwude J.L.
        Interstitial cystitis.
        J. Obstet. Gynaecol. 2004; 24: 216-225
        • Sigala S.
        • Mirabella G.
        • Peroni A.
        • Pezzotti G.
        • Simeone C.
        • Spano P.
        • Cunico S.C.
        Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder.
        Urology. 2002; 60: 719-725
        • Smith C.P.
        • Vemulakonda V.M.
        • Kiss S.
        • Boone T.B.
        • Somogyi G.T.
        Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
        Neurochem. Int. 2005; 47: 291-297
        • Sun Y.
        • Chai T.C.
        Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis.
        Am. J. Physiol. Cell Physiol. 2006; 290: C27-C34
        • Teichman J.M.
        • Moldwin R.
        The role of the bladder surface in interstitial cystitis/painful bladder syndrome.
        Can. J. Urol. 2007; 14: 3599-3607
        • Tobin G.
        • Sjogren C.
        In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]acetylcholine in the rabbit urinary bladder.
        Eur. J. Pharmacol. 1995; 281: 1-8
        • Tyagi S.
        • Tyagi P.
        • Van-Le S.
        • Yoshimura N.
        • Chancellor M.B.
        • De Miguel F.
        Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor.
        J. Urol. 2006; 176: 1673-1678
        • Wang P.
        • Luthin G.R.
        • Ruggieri M.R.
        Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.
        J. Pharmacol. Exp. Ther. 1995; 273: 959-966
        • Wang Z.
        • Shi H.
        • Wang H.
        Functional M3 muscarinic acetylcholine receptors in mammalian hearts.
        Br. J. Pharmacol. 2004; 142: 395-408
        • Venepalli B.R.
        • Aimone L.D.
        • Appell K.C.
        • Bell M.R.
        • Dority J.A.
        • Goswami R.
        • Hall P.L.
        • Kumar V.
        • Lawrence K.B.
        • Logan M.E.
        • et al.
        Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles.
        J. Med. Chem. 1992; 35: 374-378
        • Vesela R.
        • Aronsson P.
        • Tobin G.
        Functional and morphological examinations of P1A1 purinoceptors in the normal and inflamed rat urinary bladder.
        Auton. Neurosci. 2011; 159 (Electronic publication ahead of print 2010 Aug 3): 26-31
        • Vizzard M.A.
        • Erdman S.L.
        • De Groat W.C.
        Localization of NADPH diaphorase in bladder afferent and postganglionic efferent neurons of the rat.
        J. Auton. Nerv. Syst. 1993; 44: 85-90